Salva, Kim Bailey F.
HRN: 26-93-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/13/2025
04/20/2025
IV
275mg
Q6h
PCAP C
Waiting Final Action
Indication: Culture-directed Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes